A massive undertaking to determine the sequence of the several billion DNA building blocks that represent the human genome is almost complete. Pediatricians can look forward to new molecular tests for diagnosing inherited disorders in the near future. Novel therapies should follow.
Dupilumab (Dupixent) becomes first FDA-approved drug for adolescent CRSwNP
September 13th 2024The landmark indication is supported by a couple of pivotal trials assessing dupilumab for patients with chronic rhinosinusitis with nasal polyps, as well as a pediatric severe asthma trial assessing the biologic.